| Analysis | Samples | Factors | Units |
|---|---|---|---|
| HILIC POSITIVE ION MODE | Plasma_2012 | Genotype:CHCHD10S59L/+ | Gender:female | Stage:Pre-symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2016 | Genotype:CHCHD10S59L/+ | Gender:female | Stage:Pre-symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2017 | Genotype:CHCHD10S59L/+ | Gender:female | Stage:Pre-symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2025 | Genotype:CHCHD10S59L/+ | Gender:female | Stage:Pre-symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_1675 | Genotype:CHCHD10S59L/+ | Gender:female | Stage:Symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2768 | Genotype:CHCHD10S59L/+ | Gender:female | Stage:Symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2769 | Genotype:CHCHD10S59L/+ | Gender:female | Stage:Symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2801 | Genotype:CHCHD10S59L/+ | Gender:Male | Stage:Pre-symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2007 | Genotype:CHCHD10S59L/+ | Gender:Male | Stage:Symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2009 | Genotype:CHCHD10S59L/+ | Gender:Male | Stage:Symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2010 | Genotype:CHCHD10S59L/+ | Gender:Male | Stage:Symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2021 | Genotype:CHCHD10S59L/+ | Gender:Male | Stage:Symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_QC1 | Genotype:QC | Gender:QC | Stage:QC | Relative units |
| HILIC POSITIVE ION MODE | Plasma_QC2 | Genotype:QC | Gender:QC | Stage:QC | Relative units |
| HILIC POSITIVE ION MODE | Plasma_QC3 | Genotype:QC | Gender:QC | Stage:QC | Relative units |
| HILIC POSITIVE ION MODE | Plasma_QC4 | Genotype:QC | Gender:QC | Stage:QC | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2014 | Genotype:Wild-type | Gender:female | Stage:Pre-symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2015 | Genotype:Wild-type | Gender:female | Stage:Pre-symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2024 | Genotype:Wild-type | Gender:female | Stage:Pre-symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2027 | Genotype:Wild-type | Gender:female | Stage:Pre-symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_1674 | Genotype:Wild-type | Gender:female | Stage:Symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2772 | Genotype:Wild-type | Gender:female | Stage:Symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2773 | Genotype:Wild-type | Gender:female | Stage:Symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2800 | Genotype:Wild-type | Gender:Male | Stage:Pre-symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2008 | Genotype:Wild-type | Gender:Male | Stage:Symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2018 | Genotype:Wild-type | Gender:Male | Stage:Symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2019 | Genotype:Wild-type | Gender:Male | Stage:Symptomatic | Relative units |
| HILIC POSITIVE ION MODE | Plasma_2020 | Genotype:Wild-type | Gender:Male | Stage:Symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2012 | Genotype:CHCHD10S59L/+ | Gender:female | Stage:Pre-symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2016 | Genotype:CHCHD10S59L/+ | Gender:female | Stage:Pre-symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2017 | Genotype:CHCHD10S59L/+ | Gender:female | Stage:Pre-symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2025 | Genotype:CHCHD10S59L/+ | Gender:female | Stage:Pre-symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_1675 | Genotype:CHCHD10S59L/+ | Gender:female | Stage:Symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2768 | Genotype:CHCHD10S59L/+ | Gender:female | Stage:Symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2769 | Genotype:CHCHD10S59L/+ | Gender:female | Stage:Symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2801 | Genotype:CHCHD10S59L/+ | Gender:Male | Stage:Pre-symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2007 | Genotype:CHCHD10S59L/+ | Gender:Male | Stage:Symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2009 | Genotype:CHCHD10S59L/+ | Gender:Male | Stage:Symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2010 | Genotype:CHCHD10S59L/+ | Gender:Male | Stage:Symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2021 | Genotype:CHCHD10S59L/+ | Gender:Male | Stage:Symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_QC1 | Genotype:QC | Gender:QC | Stage:QC | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_QC2 | Genotype:QC | Gender:QC | Stage:QC | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_QC3 | Genotype:QC | Gender:QC | Stage:QC | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_QC4 | Genotype:QC | Gender:QC | Stage:QC | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2014 | Genotype:Wild-type | Gender:female | Stage:Pre-symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2015 | Genotype:Wild-type | Gender:female | Stage:Pre-symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2024 | Genotype:Wild-type | Gender:female | Stage:Pre-symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2027 | Genotype:Wild-type | Gender:female | Stage:Pre-symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_1674 | Genotype:Wild-type | Gender:female | Stage:Symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2772 | Genotype:Wild-type | Gender:female | Stage:Symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2773 | Genotype:Wild-type | Gender:female | Stage:Symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2800 | Genotype:Wild-type | Gender:Male | Stage:Pre-symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2008 | Genotype:Wild-type | Gender:Male | Stage:Symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2018 | Genotype:Wild-type | Gender:Male | Stage:Symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2019 | Genotype:Wild-type | Gender:Male | Stage:Symptomatic | Relative units |
| Reversed phase NEGATIVE ION MODE | Plasma_2020 | Genotype:Wild-type | Gender:Male | Stage:Symptomatic | Relative units |
Return to study ST002435 main page
Download data matrix(Metabolomics analysis of plasma from CHCHD10S59L/+ KI mice HILIC POSITIVE ION MODE)
Download data matrix(Metabolomics analysis of plasma from CHCHD10S59L/+ KI mice Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|